• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

NuVision Biotherapies

To add a bio or update company history click update information.

News from NuVision Biotherapies

    NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditionsNuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions
    NuVision Biotherapies
    5 Feb 2026

    NuVision Biotherapies unlocks £4.8m in funding led by Mercia Ventures to speed up the healing of eye conditions

    NuVision Biotherapies develops ophthalmic products based on amniotic membrane tissue. Its treatments are used to support healing after eye surgery and manage chronic eye conditions.

NuVision Biotherapies
  • Life Sciences
  • Nottingham, United Kingdom
  • £4.8m
  • nu-vision.co.uk
  • Update Information

More venture news

  • Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
    Imperagen
    21 May 2026

    Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering

    SeedLife Sciences
  • Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
    Infex Therapeutic
    12 May 2026

    Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments

    EquityLife Sciences
  • Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
    Scarlet Therapeutics
    11 May 2026

    Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn